Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Nano Mobile Healthcare Inc engages in developing a platform technology that analyzes Volatile Organic Compound signatures in a person’s breath by using a handheld device providing immediate results. The company has identified two markets been the detection of lung cancer and the presence of marijuana in a driver’s breath. Its secondary device testing indications include forms of cancer, chronic diseases such as heart failure as well as or contagious diseases such as strep throat. Its sensor can be connected through Bluetooth to any capable smart device running an iOS or Android operating system.
New York, NY, 10019